Skip to main content

Gabelli Funds LLC

SEC CIK
0001081407
Latest filing
Aug 12, 2026

MNPR holding history

Monopar Therapeutics in every 13F filed by Gabelli Funds LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MNPR overviewAll 13F holders of MNPRFull Q2 2026 holdings

Shares (Q2 2026)
2,500
Value
$231.5K
% of portfolio
<0.1%
Quarters held
1
Since Q2 2026
Holdings of MNPR by Gabelli Funds LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,500$231.5K<0.1%+2,500NewHolders